Interestingly, data from previous literature indicated that WNT2B promoted the development of multiple cancers, including NPC (25, 26), cervical cancer (36), ovarian cancer (37), and so on, indicating that WNT2B acted as an oncogene and exerted opposite effects with microRNA-338-5p in regulating cancer progression. Here, WNT2B is linked to ovarian cancer.